Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion.
Share this article
Corporate
Score 85
Bullish
Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion
Mar 28, 2026 20:55 UTC
MRK, CL=F, ^VIX
Short term
Related Articles
Score 65
Bullish
SpaceX And Anthropic IPO Frenzy Begins Early As REX Shares, Tuttle Capital File For 2x Leveraged ETFs
Mar 28, 22:31
Score 10
Wealthy Investors With 7-Figure Stock Portfolios Still Rejected by Landlords
Mar 28, 22:31
Score 35
VCIT vs. IGIB: Which Corporate Bond ETF Is Safer?
Mar 28, 22:30
Score 78
Bearish
Oracle stock dividend under threat amid massive AI push
Mar 28, 22:07
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.